Arginase and autoimmune inflammation in the central nervous system

Immunology

Volumn 110, Issue 1, 2003, Pages 141-148

  Xu, Lingyun ^a   Hilliard, Brendan ^a   Carmody, Ruaidhrí J ^a   Tsabary, Galit ^a   Shin, Hyunshun ^a   Christianson, David W ^a   Chen, Youhai H ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO 6 BORONOHEXANOIC ACID; ARGINASE; CYTOKINE; ENZYME INHIBITOR; GAMMA INTERFERON; MESSENGER RNA; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; DNA MICROARRAY; ENZYME ASSAY; ENZYME INHIBITION; GENE EXPRESSION; MICROGLIA; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; SPINAL CORD;

AMINOCAPROIC ACIDS; ANIMALS; ARGINASE; BLOTTING, NORTHERN; BORON COMPOUNDS; CELLS, CULTURED; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME INHIBITORS; MICE; MICE, INBRED C57BL; NITRIC OXIDE; RNA, MESSENGER; SPINAL CORD; SPLEEN; UP-REGULATION;

EID: 0041817795     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2003.01713.x     Document Type: Article

References (28)

1. Miller SD, Karpus WJ. The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases. Immunol Today 1994; 15:356-61.
2. Zamvil SS, Steinman L. The T lymphocyte in experimental allergic encephalomyelitis. Annu Rev Immunol 1990; 8:579-621.
3. Carmody RJ, Hilliard B, Maguschak K, Chodosh LA, Chen YH. Genomic scale profiling of autoimmune inflammation in the central nervous system: the nervous response to inflammation. J Neuroimmunol 2002; 133:95-107.
4. Jenkinson CP, Grody WW, Cederbaum S.D. Comparative properties of arginases. Comp Biochem Physiol 1996; 114:107-32.
5. Liu TS, Hilliard B, Samoilova EB, Chen Y. Differential roles of Fas ligand in spontaneous and actively induced autoimmune encephalomyelitis. Clin Immunol 2000; 95:203-11.
6. Hilliard B, Wilmen A, Seidel C, Liu TS, Goke R, Chen Y. Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis. J Immunol 2001; 166:1314-9.
7. Munder M, Eichmann K, Moran JM, Centeno F, Soler G, Modolell M. Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. J Immunol 1999; 163:3771-7.
8. Xiao BG, Xu LY, Yang JS, Huang YM, Link H. An alternative pathway of nitric oxide production by rat astrocytes requires specific antigen and T cell contact. Neurosci Lett 2000; 283:53-6.
9. Hilliard B, Mason N, Xu L, Sun J, Lamhamedi-Cherradi S-E, Liou H-C, Hunter C, Chen Y. Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation. J Clin Invest 2002; 110:843-50.
10. Song K, Chen Y, Goke R, Wilmen A, Seidel C, Goke A, Hilliard B, Chen Y. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression. J Exp Med 2000; 191:1095-104.
11. 2-arginase by borate leads to the design of a transition state analog inhibitor, 2(S)-amino-6-boronohexanoic acid. J Am Chem Soc 1997; 119:8107-8.
12. Cox JD, Baggio RF, Emig FA et al. Biochemical and functional profile of a newly developed potent and isozyme-selective arginase inhibitor. Biochemistry 2001; 40:2678-88.
13. Baggio R, Emig FA, Christianson DW, Ash DE, Chakder S, Rattan S. Biochemical and functional profile of a newly developed potent and isozyme-selective arginase inhibitor. J Pharmacol Exp Ther 1999; 290:1409-16.
14. Iniesta V, Gomez-Nieto LC, Corraliza I. The inhibition of arginase by N(omega)-hydroxy-1-arginine controls the growth of Leishmania inside macrophages. J Exp Med 2001; 193:777-84.
15. Iniesta V, Gomez-Nieto LC, Molano I, Mohedano A, Carcelen J, Miron C, Alonso C, Corraliza I. Arginase I induction in macrophages, triggered by Th2-type cytokines, supports the growth of intracellular Leishmania parasites. Parasite Immunol 2002; 24:113-8.
16. Hesse M, Modolell M, La Flamme AC, Schito M, Fuentes JM, Cheever AW, Pearce EJ, Wynn TA. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of 1-arginine metabolism. J Immunol 2001; 167:6533-44.
17. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 2000; 164:6166-73.
18. Bogdan C. The multiplex function of nitric oxide in (auto) immunity. J Exp Med 1998; 187:1361-5.
19. Kolb H, Kolb-Bachofen V. Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator? Immunol Today 1998; 19:556-61.
20. Hewett SJ, Misko TP, Keeling RM, Behrens MM, Choi DW, Cross AH. Murine encephalitogenic lymphoid cells induce nitric oxide synthase in primary astrocytes. J Neuroimmunol 1996; 64:201-8.
21. Smith KJ, Kapoor R, Felts PA. Demyelination: the role of reactive oxygen and nitrogen species. Brain Pathol 1999; 9:69-92.
22. Cowden WB, Cullen FA, Staykova MA, Willenborg DO. Nitric oxide is a potential down-regulating molecule in autoimmune disease: inhibition of nitric oxide production renders PVG rats highly susceptible to EAE. J Neuroimmunol 1998; 88:1-8.
23. O'Brien NC, Charlton B, Cowden WB, Willenborg DO. Nitric oxide plays a critical role in the recovery of Lewis rats from experimental autoimmune encephalomyelitis and the maintenance of resistance to reinduction. J Immunol 1999; 163:6841-7.
24. Fenyk-Melody JE, Garrison AE, Brunnert SR, Weidner JR, Shen F, Shelton BA, Mudgett JS. Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene. J Immunol 1998; 160:2940-6.
25. Sahrbacher UC, Lechner F, Eugster HP, Frei K, Lassmann H, Fontana A. Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis. Eur J Immunol 1998; 28:1332-8.
26. Okuda Y, Sakoda S, Fujimura H, Yanagihara T. Nitric oxide via an inducible isoform of nitric oxide synthase is a possible factor to eliminate inflammatory cells from the central nervous system of mice with experimental allergic encephalomyelitis. J Neuroimmunol 1997; 73:107-16.
27. + T cells. J Neuroimmunol 1999; 97:25-36.
28. Xu LY, Yang JS, Link H, Xiao BG. SIN-1, a nitric oxide donor, ameliorates experimental allergic encephalomyelitis in Lewis rats in the incipient phase: the importance of the time window. J Immunol 2001; 166:5810-6.